Kenya vs Kyrgyzstan: Average cost of tuberculosis treatment multi drug resistant
Kenya
1,800
in 2024
Kyrgyzstan
1,607
in 2022
Kenya rank
26th
Kyrgyzstan rank
29th
Average cost of tuberculosis treatment multi drug resistant over time
- Kenya
- Kyrgyzstan
How they compare
Kenya currently reports 1,800 against 1,607 in Kyrgyzstan, a difference of 193.
That makes Kenya's figure about 1.1 times Kyrgyzstan's.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was Kyrgyzstan ahead.
Kenya ranks 26th and Kyrgyzstan ranks 29th of 92 countries.
Across the 2 decades both report, Kenya averaged higher in 1 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Kenya | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,883 | 2,218 | 665.67 | Kenya |
| 2020s | 1,644 | 1,761 | 116.67 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment multi drug resistant, Kenya or Kyrgyzstan?
- Kenya, at 1,800 against 1,607 in Kyrgyzstan as of 2024.
- What is the difference in average cost of tuberculosis treatment multi drug resistant between Kenya and Kyrgyzstan?
- 193, with Kenya ahead.
- How many years of comparable data are there for Kenya and Kyrgyzstan?
- 6 years are reported by both, from 2017 to 2022.
- How do Kenya and Kyrgyzstan rank globally for average cost of tuberculosis treatment multi drug resistant?
- Kenya ranks 26th and Kyrgyzstan ranks 29th of 92 countries.
- Where does this data come from?
- Our World in Data, published as Average cost of tuberculosis treatment multi drug resistant. Statizoid refreshes it automatically from the source and publishes the full history for both places.